China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China
· Delayed Price · Currency is CNY 20.92
+0.03 (0.14%)
Mar 10, 2026, 11:44 AM CST
SHE:300294 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 10,534 | 15,269 | 16,983 | 18,435 | 19,338 | 14,286 | Upgrade
|
| Market Cap Growth | -28.34% | -10.10% | -7.88% | -4.67% | 35.36% | 7.40% | Upgrade
|
| Enterprise Value | 7,427 | 10,035 | 11,919 | 13,978 | 17,731 | 14,221 | Upgrade
|
| Last Close Price | 20.89 | 29.91 | 32.80 | 35.41 | 36.96 | 32.27 | Upgrade
|
| PE Ratio | 32.13 | 38.46 | 71.52 | 42.66 | 56.13 | 54.93 | Upgrade
|
| Forward PE | 18.53 | 26.00 | 29.00 | 30.95 | 32.40 | 32.75 | Upgrade
|
| PS Ratio | 5.36 | 8.80 | 6.40 | 6.68 | 7.30 | 5.69 | Upgrade
|
| PB Ratio | 1.37 | 2.04 | 2.32 | 2.53 | 2.79 | 3.41 | Upgrade
|
| P/TBV Ratio | 1.68 | 2.55 | 2.43 | 2.97 | 3.23 | 4.40 | Upgrade
|
| P/FCF Ratio | - | 149.71 | 30.64 | 40.25 | 15.14 | 24.80 | Upgrade
|
| P/OCF Ratio | 165.93 | 50.93 | 26.47 | 30.91 | 14.37 | 19.88 | Upgrade
|
| EV/Sales Ratio | 3.78 | 5.78 | 4.49 | 5.07 | 6.69 | 5.66 | Upgrade
|
| EV/EBITDA Ratio | 20.64 | 19.30 | 19.09 | 23.28 | 34.72 | 34.56 | Upgrade
|
| EV/EBIT Ratio | 28.90 | 23.77 | 22.52 | 27.56 | 42.78 | 43.07 | Upgrade
|
| EV/FCF Ratio | -17.36 | 98.40 | 21.51 | 30.52 | 13.88 | 24.69 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 0.02 | 0.02 | 0.04 | 0.06 | 0.07 | 0.80 | Upgrade
|
| Debt / FCF Ratio | - | 0.12 | 0.04 | 0.08 | 0.03 | 0.57 | Upgrade
|
| Net Debt / Equity Ratio | -0.40 | -0.47 | -0.72 | -0.64 | -0.61 | -0.10 | Upgrade
|
| Net Debt / EBITDA Ratio | -8.71 | -6.71 | -8.49 | -7.81 | -8.32 | -1.03 | Upgrade
|
| Net Debt / FCF Ratio | 7.26 | -34.18 | -9.56 | -10.24 | -3.33 | -0.73 | Upgrade
|
| Asset Turnover | 0.23 | 0.21 | 0.33 | 0.35 | 0.42 | 0.48 | Upgrade
|
| Inventory Turnover | 1.00 | 0.79 | 2.06 | 1.87 | 1.74 | 1.61 | Upgrade
|
| Quick Ratio | 4.29 | 5.40 | 12.85 | 7.65 | 7.83 | 1.71 | Upgrade
|
| Current Ratio | 5.57 | 6.74 | 14.08 | 8.61 | 8.95 | 3.36 | Upgrade
|
| Return on Equity (ROE) | 4.29% | 5.36% | 3.40% | 6.27% | 6.45% | 6.73% | Upgrade
|
| Return on Assets (ROA) | 1.90% | 3.25% | 4.17% | 4.05% | 4.05% | 3.96% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.50% | 11.64% | 16.09% | 16.13% | 10.41% | 7.09% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.30% | 5.50% | 7.20% | 6.90% | 5.90% | 7.70% | Upgrade
|
| Earnings Yield | 3.11% | 2.60% | 1.40% | 2.34% | 1.78% | 1.82% | Upgrade
|
| FCF Yield | -4.06% | 0.67% | 3.26% | 2.48% | 6.60% | 4.03% | Upgrade
|
| Dividend Yield | 1.41% | 1.07% | 0.92% | 0.56% | 0.41% | 0.20% | Upgrade
|
| Payout Ratio | 72.56% | 58.54% | 42.47% | 19.25% | 13.36% | 34.15% | Upgrade
|
| Buyback Yield / Dilution | 0.22% | 0.54% | -0.53% | -15.24% | -2.30% | -0.04% | Upgrade
|
| Total Shareholder Return | 1.63% | 1.61% | 0.38% | -14.67% | -1.89% | 0.16% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.